Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Tom Allinder who wrote (38455)	3/21/2000 7:31:00 PM
From: rocket_no9	Respond to of 150070

ASTM---> Tom, would appreciate your opinion on this News... AASTROM BIOSCIENCES INC files for common stock offer. Excerpted from S-3 filed on 03/21 by AASTROM BIOSCIENCES INC: AASTROM BIOSCIENCES INC files for common stock offer. PROSPECTUS 3,396,226 SHARES OF COMMON STOCK AASTROM BIOSCIENCES, INC. This Prospectus relates to the offer and sale of 3,396,226 shares of common stock being offered by RGC International Investors, LDC. These shares include 1,132,075 shares that are issuable upon exercise of warrants. Our common stock is quoted on the Nasdaq National Market under the symbol "ASTM." The selling stockholder will determine the price it may offer or sell shares of our common stock independent of Aastrom. On March 17, 2000, the last sale price of our common stock was $5.8125. INVESTING IN THE COMMON STOCK INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD CONSIDER CAREFULLY THE RISK FACTORS BEGINNING ON PAGE 4 OF THIS PROSPECTUS BEFORE MAKING A DECISION TO PURCHASE OUR STOCK. NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. THE DATE OF THIS PROSPECTUS IS MARCH __, 2000. (End of Item Excerpt) (End of Item Excerpt) USE OF PROCEEDS Aastrom will not receive any proceeds from sales of the shares. We will receive up to approximately $4.2 million upon exercise of the warrants. This is based on a potential full exercise of the warrants to purchase 1,132,075 shares of common stock at $3.695 per share. We intend to apply any net proceeds received from exercise of the warrants to general working capital purposes. LEGAL MATTERS The validity of the common stock offered hereby will be passed upon for Aastrom by Pepper Hamilton LLP, Detroit, Michigan. Gray Cary Ware & Freidenrich LLP, San Diego, California, has acted as special counsel to Aastrom in connection with this offering. EXPERTS The financial statements incorporated in this Prospectus by reference to the Current Report on Form 8-K filed with the Commission on December 10, 1999, have been so incorporated in reliance on the report (which contains an explanatory paragraph relating to the Company's ability to continue as a going concern and described in Note 1 to the Financial Statements) of PricewaterhouseCoopers LLP, independent accountants, given on the authority of said firm as experts in auditing and accounting.